Evidence map›Paper›PMID 36321841›Full record

ArticleACS applied materials & interfaces2022

Highly Active and Stable Ni/La-Doped Ceria Material for Catalytic CO

Consuelo Alvarez-Galvan, Pablo G Lustemberg, Freddy E Oropeza, Belén Bachiller-Baeza, Martin Dapena Ospina, María Herranz, Jesús Cebollada, Laura Collado, José M Campos-Martin, Víctor A de la Peña-O'Shea and 2 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Growth and interface formation in CeONanoscale advances · 2026
    Article
  2. Samarium-Driven Vacancy Engineering in CeOChemistry of materials : a publication of the American Chemical Society · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Consuelo Alvarez-GalvanInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0002-2574-4909
Pablo G LustembergInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0003-4058-4023
Freddy E OropezaPhotoactivated Processes Unit, IMDEA Energy Institute, Avda. Ramón de la Sagra 3, Móstoles, Madrid28935, Spain.
Belén Bachiller-BaezaInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0002-7205-5997
Martin Dapena OspinaInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0003-3104-5482
María HerranzInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.
Jesús CebolladaInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.
Laura ColladoPhotoactivated Processes Unit, IMDEA Energy Institute, Avda. Ramón de la Sagra 3, Móstoles, Madrid28935, Spain.
José M Campos-MartinInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0002-7913-9851
Víctor A de la Peña-O'SheaPhotoactivated Processes Unit, IMDEA Energy Institute, Avda. Ramón de la Sagra 3, Móstoles, Madrid28935, Spain.ORCID 0000-0001-5762-4787
José A AlonsoInstituto de Ciencia de Materiales de Madrid (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0001-5329-1225
M Verónica Ganduglia-PirovanoInstituto de Catálisis y Petroleoquímica (CSIC), Cantoblanco, Madrid28049, Spain.ORCID 0000-0003-2408-8898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of an active, effective, and economically viable catalyst for CO

Indexed as

CeO2DFT calculationsLa-dopingnickelrWGS

Identifiers

PMID36321841
PMCPMC9673058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.